Management of Chronic Low Back Pain

Management of Chronic Low Back Pain
Please read through the following information and click continue.

ACPE Universal Program Number: 207-000-08-007-H04-P
Release Date: July 1, 2008
Expiration Date: July 1, 2011

Statement of Need
According to a national survey from 2002, low back pain was identified as the fifth most common reason for all physician visits in the United States and is reported to affect about 6 percent of American adults each day. The lifetime prevalence of low back pain is estimated to be between 60–70 percent; however, only 25–30 percent of those afflicted will seek medical care. Most patients with acute low back pain will experience symptom resolution within four to six weeks, and after three months, 80–90 percent of patients will improve regardless of treatment modality.

The remaining 10 percent of patients will progress to develop chronic low back pain, defined as pain that is present for greater than three months, which is beyond the time it normally takes for tissue to heal. Between 20–45 percent of patients who have experienced an episode of low back pain are likely to have a recurrence within one year, with as many as 85 percent developing a recurrence in their lifetime. Direct health care costs attributable to low back pain were estimated at $26.3 billion in 1998, and chronic low back pain accounts for 65–85 percent of these costs.

Learning Objectives
Upon successful completion of this activity, the pharmacist should be able to:

  1. Discuss the incidence, prevalence, and economic burden of chronic low back pain in the United States.
  2. Identify the categories used to differentiate low back pain.
  3. Identify the goals of therapy for the management of chronic low back pain.
  4. Compare and contrast the available treatment options for chronic low back pain.
  5. Be able to provide important counseling points to patients who are experiencing chronic low back pain.

Target Audience
The target audience for this activity is pharmacists.

Instructions for Participation
To receive a certificate of completion that indicates your eligibility for continuing education credit, you must:

  • Review the content of the activity.
  • Successfully complete the post-test (70% or higher).
  • You will have two (2) opportunities to successfully complete the activity.

Your statement of credit will be issued immediately upon successful completion of the post-test and submission of the evaluation.

Fee
There is no fee for this activity.

Accreditation
Pharmacists
ACPE logoNCPA is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program will provide 2.0 contact hours (.20 CEUs) of continuing pharmacy education credit under the number 207-000-08-007-H04-P.

 

Faculty
Michele Matthews, PharmD, RPh, is an assistant professor of pharmacy practice at the Massachusetts College of Pharmacy and Health Sciences, and an adjunct assistant professor of Family Medicine and Community Health at the University of Massachusetts Medical School, both in Worcester, Massachusetts.

Disclosure Declaration
It is the policy of the National Community Pharmacists Association (NCPA) to ensure independence, balance, objectivity, scientific rigor, and integrity in all of their continuing education activities.

The author, sponsor, and publisher of this continuing education activity have made all reasonable efforts to ensure that information contained herein is accurate in accordance with the latest available scientific knowledge at the time of accreditation of this continuing education program. Information regarding drugs (e.g., their administration, dosages, contraindications, adverse reactions, interactions, special warnings, precautions) and drug delivery systems are subject to change, however, the reader is advised to check the manufacturer's package insert for information concerning recommended dosage and potential problems or cautions prior to dispensing or administering the drug or using the drug delivery systems.

Approval of credit for this continuing education activity does not imply endorsement by NCPA of any product or manufacturer identified.

Any medications or treatment methods suggested in this CE activity should not be used by the practitioner without evaluation of their patient's condition(s) and possible contraindication(s) or danger(s) of use of any specific medication.

Software Requirement

PC
Windows 2000
Internet Explorer 5.5 or Firefox
*Adobe Acrobat Reader

MAC
Mac OS 10.2.8
Safari

*Adobe Acrobat Reader

*REQUIRED TO VIEW PRINTABLE VERSION OF CE LESSON

 

 

 




Continue